Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: Implications for ischemia and Huntington's disease

Annals of Neurology

Volumn 43, Issue 5, 1998, Pages 586-597

  Calabresi, Paolo ^a   Centonze, Diego ^a   Pisani, Antonio ^a   Sancesario, Giuseppe ^a   Gubellini, Paolo ^a,b   Marfia, Girolama A ^a   Bernardi, Giorgio ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR AGONIST; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ARTICLE; BRAIN ISCHEMIA; CELL MEMBRANE DEPOLARIZATION; CHOLINERGIC NERVE CELL; CORPUS STRIATUM; EXCITATORY POSTSYNAPTIC POTENTIAL; HUNTINGTON CHOREA; INTERNEURON; NONHUMAN; PRIORITY JOURNAL; RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BRAIN ISCHEMIA; CELLS, CULTURED; CEREBRAL CORTEX; CHOLINERGIC FIBERS; CORPUS STRIATUM; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; HUNTINGTON DISEASE; INTERNEURONS; KAINIC ACID; MEMBRANE POTENTIALS; N-METHYLASPARTATE; NEUROTOXINS; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 0031978837     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430506     Document Type: Article

References (77)

1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375
2. Albin RL, Greenamyre JT. Alternative excitotoxic hypothesis. Neurology 1992;42:733-738
3. Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990;13:133-254
4. Cakbresi P, Pisani A, Mercuri NB, Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci 1996;19:19-24
5. Lapper SR, Bolam JP. Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuroscience 1992;51:533-545
6. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-695
7. Meldrum BS, Garthwaite J. Excitatory amino acid and neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990;11:379-387
8. Lipton SA, Rosemberg PA. Excitatory amino acids as final common pathway for neurologic disorders. N Engl J Med 1994; 330:613-622
9. Beal MF. Aging, energy and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-366
10. Auer RN, Siesjo BK. Biological differences between ischemia, hypoglycemia and epilepsy. Ann Neurol 1988;24:699-707
11. Choi DW. Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci 1990;10:2493-2501
12. Choi DW, Rothmann SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990; 13:171-182
13. Martin RL, Lloyd HGE, Cowan AI. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci 1994;17:251-257
14. Obrenovitch TP, Urenjak J. Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog Neurobiol 1997;51:39-87
15. Pulsinelli WA, Brietley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982;11:491-498
16. Pulsinelli WA. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res 1985;63:9-37
17. Young AB, Greenamyre JT, Hollingworth Z. NMDA receptor losses in putamen from patients with Huntington's disease. Science 1988;241:981-983
18. Chesselet M-F, Gonzales C, Lin CS, et al. Ischemic damage in th striatum of adult gerbils: relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons. Exp Neurol 1990;110:209-218
19. DiFiglia M. Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci 1990;13:286-289
20. Meldrum BS. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Dis 1990;4:26-31
21. Muir KW, Lees KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke 1995;26:503-513
22. McGeer EG, M4cGeer PL. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamate and kainic acid. Nature 1976;263:517-519
23. Beal MF, Ferrante RJ, Swartz KJ, Kowall NW. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J Neurosci 1991;11:1649-1659
24. Francis A, Pulsinelli W. The response of GABAergic and cholinergic neurons to transient cerebral ischemia. Brain Res 1982; 243:271-278
25. Ferrante RJ, Kowall NW, Beal MF, et al. Selective sparing of a class of striatal neurons in Huntington's disease. Science 1985; 230:561-563
26. Ferrante RJ, Beal MF, Kowall NW, et al. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res 1987;411:162-166
27. Hawker K, Lang AE. Hypoxic-ischemic damage of the basal ganglia: case reports and a review of the literature. Mov Disord 1990;5:219-224
28. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 1994;17:31-108
29. Landwehrmeyer GB, Standaert DG, Testa CM, et al. NMDA receptor subunits mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci 1995;15:297-307
30. Chen Q, Veenman CL, Reiner A. Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate-mediated excitotoxicity. Neuroscience 1996;73:715-731
31. Tallaksen-Greene SJ, Albin RL. Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons. Neuroscience 1996;75:1057-1064
32. Bernard V, Somogyi P, Bolam JP. Cellular, subcellular and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J Neurosci 1997;17:819-833
33. Calabresi P, De Murtas M, Mercuri NB, Bernardi G. Kainic acid on neostriatal neurons intracellularly recorded in vitro: electrophysiological evidence for differential neuronal sensitivity. J Neurosci 1990;10:3960-3969
34. Calabresi P, Mercuri NB, Bernardi G. Synaptic and intrinsic control of membrane excitability of neostriatal neurons: II. An in vitro analysis. J Neurophysiol 1990;63:663-675
35. Calabresi P, Mercuri NB, Stefani A, Bernardi G. Synaptic and intrinsic control of membrane excitability of neostriatal neurons: I. An in vivo analysis. J Neurophysiol 1990;63:651-662
36. Calabresi P, Mercuri NB, Sancesario G, Bernardi G. Electrophysiology of dopamine-denervated striatal neurons: implications for Parkinson's disease. Brain 1993;116:433-452
37. + ATPase. Eur J Neurosci 1995;7:1674-1683
38. Calabresi P, Pisani A, Mercuri NB, Bernardi G. On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. Brain 1995;118:1027-1038
39. Calabresi P, Magarinos Ascone C, Centonze D, et al. Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons. J Neurosci 1997;17:1940-194
40. Horikawa H, Armstrong WE. A versatile mean of intracellular labelling: injection of biocytin and its detection with avidin conjugates. J Neurosci Methods 1988;25:1-11
41. Preston RJ, Bishop GA, Kitai ST. Medium spiny neuron projection from the rat striatum: an intracellular horse-radish peroxidase study. Brain Res 1979;183:253-258
42. Kita T, Kita H, Kitai ST. Passive electrical membrane properties of rat neosttiatal neurons in an in vitro slice preparation. Brain Res 1984;300:129-139
43. Jiang Z-C, North RA. Membrane properties and synaptic responses of rat striatal neurons in vitro. J Physiol (London) 1991,443:533-553
44. Cepeda C, Walsh JP, Peacock W, et al. Neurophysiological, pharmacological and morphological properties of human caudate neurons recorded in vitro. Neuroscience 1994;59:89-103
45. Wilson CJ, Chang HT, Kitai ST. Firing pattern and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum. J Neurosci 1990;10:508-519
46. Kawaguchi Y. Large aspiny cells in the matrix of the rat neostriatum in vitro: physiological identification, relation to the compartments and excitatory postsynaptic currents. J Neurophysiol 1992;67:1669-1682
47. Kawaguchi Y. Physiological, morphological and histochemical characterization of three classes of interneurons in the rat neostriatum. J Neurosci 1993;13:4908-4923
48. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC. Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci 1995;18:527-535
49. Gasic GP, Hollmann M. Molecular neurobiology of glutamate receptors. Am Rev Physiol 1992;54:507-536
50. Seeburg PH. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci 1993;16:359-365
51. Monyer H, Burnashev N, Laurie DJ, et al. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994;12:529-540
52. Jonas P, Burnashev N. Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron 1995;15:987-990
53. Gotz T, Kraushaar, Geiger J, et al. Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. J Neurosci 1997;17:204-215
54. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-634
55. Martin LJ, Blackstone CD, Levey AI, et al. AMPA glutamate receptor subunits are differentially distributed in the brain. Neuroscience 1993;53:327-358
56. Standaert DG, Testa CM, Young AB, Penney JB. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 1994;343:1-16
57. Ghasemzadeh MB, Sharma S, Surmeir DJ, et al. Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study. Mol Pharmacol 1996;49:852-859
58. Koh J-Y, Choi DW. Cultured striatal neurons containing NADPH-diaphorase or acetylcholinesterase are selectively resistant to injury by NMDA receptor agonists. Brain Res 1988; 446:374-378
59. Huganir RL, Greengard P. Regulation of receptor desensitization by protein phosphorylation. Neuron 1990;5:555-567
60. Tingley WG, Roche KW, Thompson AK, Huganir RL. Regulation of NMDA receptor phosphorylation by alternative splicing of C-terminal domain. Nature 1993;364:70-73
61. Beal MF, Kowall NW, Ellison DW, et al. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 1986;321:168-171
62. Davies SW, Roberts PJ. Sparing of cholinergic neurons following quinolinic lesions of the rat striatum. Neuroscience 1988; 26:387-393
63. Roberts RC, DiFiglia M. Short-and long-term survival of large neurons in the excitotoxic lesioned rat caudate nucleus: a light and electron microscopic study. Synapse 1989;3:363-371
64. Roberts RC, Ahn A, Swartz KJ, et al. Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome. Exp Neurol 1993;124:274-282
65. Whetsell WOJ, Schwarcz R. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett 1989;97:271-275
66. Vonsattel J-P, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577
67. Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988;451:205-212
68. Wilson CJ, Kawaguchi Y. The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J Neurosci 1996;16:2397-2410
69. Dawson VL, Dawson TM, Bartley AA, et al. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13:2651-2661
70. Inagaki S, Suzuki K, Taniguchi N, Takagi H. Localization of Mn-superoxide dismutase (Mn-SOD) in cholinergic and somatostatin-containing neurons in the rat neostriatum. Brain Res 1991;549:174-177
71. Sloviter RS. Calcium-binding protein (Calbindin-D28K) and parvalbumin immunohistochemistry: localization in the rat hippocampus with specific reference to selective vulnerability of hippocampal neurons to seizure activity. J Comp Neurol 1989; 280:183-196
72. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 1992;31:119-130
73. Browne SE, Bowling AC, MacGarvey U, et al. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 1997;41: 647-653
74. Pisani A, Calabresi P, Centonze D, Bernardi G. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurons. Br J Pharmacol 1997;120: 1007-1014
75. Ben-Ari Y, Aniksztejn L, Bregestovski P. Protein kinase C modulation of NMDA currents: an important link for LTP induction. Trends Neurosci 1992;15:333-339
76. Hammond C, Crepel V, Gozlan H, Ben-Ari Y. Anoxic LTP sheds light on multiple facets of NMDA receptors. Trends Neurosci 1994;17:497-503
77. 2+ and protein kinase C. Trends Pharmacol Sci 1996;17:114-120